Cell & Gene Therapy Trials: Adapting at the Speed of Science (Chapter 5 of 5)

Adam Callahan explains what adapting at the speed of science means for cell and gene therapy trials. He describes how precision medicine, artificial intelligence, machine learning, and other advanced technologies can reveal patterns within patient populations and available clinical data. The discussion explores how information from electronic medical records can be cross-referenced with physician narratives, laboratory findings, biopsies, and diagnostic imaging such as PET/CT scans and MRIs. These connected data sources can help teams identify potential trial candidates, understand relevant clinical histories, support treatment administration, and evaluate the effects of therapy.